Market Cap

Pierrel S.p.A. Market Capitalization:

€95.6 Million

EUR as of Jan. 1, 2024

US$105.6 Million

business Pierrel S.p.A. Company Profile

Pierrel S.p.A. Main Stock Listing

MTA: PRL

Market Capitalization History of Pierrel S.p.A.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—General
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
AstraZeneca $284.38 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Pierrel S.p.A. market cap

Date Market Cap YoY Change
Jan. 1, 2024 €95.6 M 131.72%
Jan. 1, 2023 €41.2 M -19.82%
Jan. 1, 2022 €51.4 M 27.70%
Jan. 1, 2021 €40.3 M 0.88%
Jan. 1, 2020 €39.9 M 6.58%
Jan. 1, 2019 €37.5 M -23.59%
Jan. 1, 2018 €49.0 M -1.89%
Jan. 1, 2017 €50.0 M -48.08%
Jan. 1, 2016 €96.3 M -37.37%
Jan. 1, 2015 €153.7 M 21.29%
Jan. 1, 2014 €126.7 M -29.86%
Jan. 1, 2013 €180.7 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Pierrel S.p.A. Categories

Italy languages Healthcare languages Drug Manufacturers—General
Italy Healthcare Italy Drug Manufacturers—General

Stocks & Indices

Pierrel S.p.A. has the following listings and related stock indices.


Stock: MTA: PRL

Stock: FSX: 2FJ

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.